Kodak names Jackman CTO

Article

Michael W. Jackman has been named chief technology officer and a divisional vice president for Kodak's Health Imaging Group. He will lead Health Imaging's global R&D operation with a strategic focus on delivering new technology, products, and services by

Michael W. Jackman has been named chief technology officer and a divisional vice president for Kodak's Health Imaging Group. He will lead Health Imaging's global R&D operation with a strategic focus on delivering new technology, products, and services by leveraging intellectual property and technology investments, according to the company. Jackman will also steer the design, development, and expansion of Health Imaging's digital product portfolio. Jackman was founder and CEO of a consulting firm specializing in technology development and strategy for companies in the wireless, IP telephony, security, and software infrastructure areas. He has held top marketing, sales, and development positions at various technology companies including IBM. Health Imaging is Kodak's second-largest business, with annual revenue of more than $2.3 billion.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.